The companies, Chiron and Aventis Pasteur, together made about 80 million doses of the injected vaccine, which ordinarily would have been enough to meet U.S. demand.
Chiron and Aventis Pasteur together made about 80 million doses, ordinarily enough for U.S. demand, The Associated Press reported.